InMode/$INMD

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About InMode

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

Ticker

$INMD
Primary listing

Industry

Health Care Equipment & Supplies

Headquarters

Yokne'am, Israel

Employees

599

ISIN

IL0011595993

InMode Metrics

BasicAdvanced
$843M
5.82
$2.29
1.96
-

What the Analysts think about InMode

Analyst ratings (Buy, Hold, Sell) for InMode stock.

Bulls say / Bears say

InMode's strong cash position of $596.5 million as of December 31, 2024, provides financial stability and flexibility for strategic investments. (wjbf.com)
The company's approval of a new share repurchase program indicates confidence in its financial health and commitment to enhancing shareholder value. (wjbf.com)
InMode's diversified product portfolio across multiple medical specialties positions it well to capture growth opportunities in various markets. (inmodemd.com)
InMode revised its full-year 2023 revenue guidance downward to $485 million to $495 million, citing stronger-than-expected macroeconomic headwinds and a slowdown in platform sales, particularly in North America. (stockhouse.com)
Analysts have downgraded InMode's stock rating to 'Neutral,' reflecting concerns over the company's growth prospects amid economic challenges. (marketbeat.com)
The company experienced a 13% pre-market stock decline following the announcement of lowered 2023 guidance, indicating investor apprehension about future performance. (seekingalpha.com)
Data summarised monthly by Lightyear AI. Last updated on 7 Jun 2025.

InMode Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

InMode Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $INMD

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs